These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 3339328)
21. Antibodies to respiratory syncytial virus polypeptides and their significance in human infection. Ward KA; Lambden PR; Ogilvie MM; Watt PJ J Gen Virol; 1983 Sep; 64 (Pt 9)():1867-76. PubMed ID: 6886679 [TBL] [Abstract][Full Text] [Related]
22. Persistent and lytic infections with SSPE virus: a comparison of the synthesis of virus-specific polypeptides. Stephenson JR; Siddell SG; Meulen VT J Gen Virol; 1981 Nov; 57(Pt 1):191-7. PubMed ID: 7320706 [TBL] [Abstract][Full Text] [Related]
23. Analysis of Marek's disease virus serotype 1-specific phosphorylated polypeptides in virus-infected cells and Marek's disease lymphoblastoid cells. Nakajima K; Ikuta K; Naito M; Ueda S; Kato S; Hirai K J Gen Virol; 1987 May; 68 ( Pt 5)():1379-89. PubMed ID: 3033141 [TBL] [Abstract][Full Text] [Related]
24. Control of protein synthesis in herpesvirus-infected cells: analysis of the polypeptides induced by wild type and sixteen temperature-sensitive mutants of HSV strain 17. Marsden HS; Crombie IK; Subak-Sharpe JH J Gen Virol; 1976 Jun; 31(3):347-72. PubMed ID: 180249 [TBL] [Abstract][Full Text] [Related]
25. Binding of neutralizing monoclonal antibodies to regions of the fusion protein of respiratory syncytial virus expressed in Escherichia coli. Lounsbach GR; Bourgeois C; West WH; Robinson JW; Carter MJ; Toms GL J Gen Virol; 1993 Dec; 74 ( Pt 12)():2559-65. PubMed ID: 7506297 [TBL] [Abstract][Full Text] [Related]
26. Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization. Wu H; Pfarr DS; Tang Y; An LL; Patel NK; Watkins JD; Huse WD; Kiener PA; Young JF J Mol Biol; 2005 Jul; 350(1):126-44. PubMed ID: 15907931 [TBL] [Abstract][Full Text] [Related]
27. Chimeric subgroup A respiratory syncytial virus with the glycoproteins substituted by those of subgroup B and RSV without the M2-2 gene are attenuated in African green monkeys. Cheng X; Zhou H; Tang RS; Munoz MG; Jin H Virology; 2001 Apr; 283(1):59-68. PubMed ID: 11312662 [TBL] [Abstract][Full Text] [Related]
28. Polypeptide phosphorylation in adenovirus-infected cells. Russell WC; Blair GE J Gen Virol; 1977 Jan; 34(1):19-35. PubMed ID: 833577 [TBL] [Abstract][Full Text] [Related]
29. Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage. Anderson K; Stott EJ; Wertz GW J Gen Virol; 1992 May; 73 ( Pt 5)():1177-88. PubMed ID: 1375280 [TBL] [Abstract][Full Text] [Related]
31. Nonreplicating vaccines can protect african green monkeys from the memphis 37 strain of respiratory syncytial virus. Eyles JE; Johnson JE; Megati S; Roopchand V; Cockle PJ; Weeratna R; Makinen S; Brown TP; Lang S; Witko SE; Kotash CS; Li J; West K; Maldonado O; Falconer DJ; Lees C; Smith GJ; White P; Wright P; Loudon PT; Merson JR; Jansen KU; Sidhu MK J Infect Dis; 2013 Jul; 208(2):319-29. PubMed ID: 23596321 [TBL] [Abstract][Full Text] [Related]
32. Membrane orientation and oligomerization of the small hydrophobic protein of human respiratory syncytial virus. Collins PL; Mottet G J Gen Virol; 1993 Jul; 74 ( Pt 7)():1445-50. PubMed ID: 8336126 [TBL] [Abstract][Full Text] [Related]
33. The characterization and uses of monoclonal antibodies to respiratory syncytial virus. Stott EJ; Bew MH; Taylor G; Jebbett J; Collins AP Dev Biol Stand; 1984; 57():237-44. PubMed ID: 6084614 [TBL] [Abstract][Full Text] [Related]
34. Mapping of monoclonal antibody epitopes of the human respiratory syncytial virus p protein. García J; García-Barreno B; Martinez I; Melero JA Virology; 1993 Jul; 195(1):239-42. PubMed ID: 7686311 [TBL] [Abstract][Full Text] [Related]
35. The purification of four respiratory syncytial virus proteins and their evaluation as protective agents against experimental infection in BALB/c mice. Routledge EG; Willcocks MM; Samson AC; Morgan L; Scott R; Anderson JJ; Toms GL J Gen Virol; 1988 Feb; 69 ( Pt 2)():293-303. PubMed ID: 3339327 [TBL] [Abstract][Full Text] [Related]
36. The production of monoclonal antibodies against respiratory syncytial virus and its clinical applications. Wu B Clin Lab Med; 1985 Sep; 5(3):589-613. PubMed ID: 3899483 [TBL] [Abstract][Full Text] [Related]
37. Protein synthesis in pupae of the silkworm Bombyx mori after infection with nuclear polyhedrosis virus: resistance to viral infection acquired during pupal period. Mikhailov VS; Zemskov EA; Abramova EB J Gen Virol; 1992 Dec; 73 ( Pt 12)():3195-202. PubMed ID: 1469357 [TBL] [Abstract][Full Text] [Related]
38. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein. Melero JA; García-Barreno B; Martínez I; Pringle CR; Cane PA J Gen Virol; 1997 Oct; 78 ( Pt 10)():2411-8. PubMed ID: 9349459 [No Abstract] [Full Text] [Related]
39. Turkey rhinotracheitis virus: in vivo and in vitro polypeptide synthesis. Ling R; Pringle CR J Gen Virol; 1988 Apr; 69 ( Pt 4)():917-23. PubMed ID: 3356982 [TBL] [Abstract][Full Text] [Related]
40. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein. López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]